France is represented by two organisations; ANR and Inserm.
The French National Research funding Agency (ANR) is a research funding organization. It was established by the French government in 2005 to fund research projects, based on competitive schemes giving researchers the best opportunities to realize their projects and paving the way for ground-breaking new knowledge. The role of the Agency is to bring more flexibility to the French research system, foster new dynamics and devise cutting edge-strategies for acquiring new knowledge. By identifying priority areas and fostering private-public collaborations, it also aims at enhancing the general level of competitiveness of both the French research system and the French economy. International activities are one of the priorities of the ANR; all scientific departments participate in ERA-Nets, JPIs and multilateral actions. In JPIAMR, ANR contributes to work packages 4, 5 and 6.
Founded in 1964, the French National Institute of Health and Medical Research (Inserm) (http://www.inserm.fr/en/) is the only French public scientific and technological institute (Research Performing Organisation) to focus entirely on human health. In 2008 Inserm took on the responsibility for the strategic, scientific and operational coordination of biomedical research. This key role as coordinator comes naturally to Inserm thanks to the scientific quality of its teams and its ability to conduct translational research, from the laboratory to the patient’s bed.
In April 2009, national coordination was strengthened by the French National Alliance for Life Sciences and Health (http://www.aviesan.fr/en/), which Inserm co-founded with other research institutes and the Association of University Presidents. To extend the strategic and programmatic coordination of research to all life and health sciences, the Alliance relies on 10 multi-organisation thematic institutes.
Lastly, Inserm plays a leading role in creating the European Research Area and boosts its standing abroad through close partnerships (teams and partner laboratories abroad). The institute is the first coordinator of Health Cooperation projects within the FP7.
Inserm and the multi-organisation thematic institute of Aviesan dedicated to Microbiology and Infectious Diseases (IMMI) will be involved in the WP3 of the JPI AMR. Aviesan is already involved in the Joint Programming Initiative on Neurodegenerative diseases.